SRRA
Sierra Oncology, Inc. Common Stock
SRRA
SRRA
Delisted
SRRA was delisted on the 30th of June, 2022.
44 hedge funds and large institutions have $48M invested in Sierra Oncology, Inc. Common Stock in 2017 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 9 increasing their positions, 7 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
44
Holders Change
+8
Holders Change %
+22.22%
% of All Funds
1.1%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
16
Increased
9
Reduced
7
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
FM
Frazier Management
Seattle,
Washington
|
+$9.07M |
| 2 |
DM
Deerfield Management
New York
|
+$5.82M |
| 3 |
PA
Perceptive Advisors
New York
|
+$5.67M |
| 4 |
O
OrbiMed
New York
|
+$5.67M |
| 5 |
NLVP
New Leaf Venture Partners
New York
|
+$3.97M |
Top Sellers
| 1 |
BBA
Baker Bros. Advisors
New York
|
-$298K |
| 2 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$223K |
| 3 |
Goldman Sachs
New York
|
-$59K |
| 4 |
JPMorgan Chase & Co
New York
|
-$40.8K |
| 5 |
VKH
Virtu KCG Holdings
New York
|
-$40.2K |
